The clinical manifestations and outcomes of coronavirus disease (COVID-19) vary among patients. Emerging evidence indicates that host genetic factors may influence disease severity. Genome-wide association studies (GWAS) have identified several genetic loci, including TYK2 and NOTCH4, as contributors to COVID-19 pathog...
M. Al-Rshaidat, A. Alsayed, Omar Al-Rshaidat et al.· Biomedical Reports· 0 citations
RIOK3 is identified as a promising therapeutic target for PDAC, with Venetoclax, Conivaptan, Drospirenone, and Irinotecan as repurposable candidates for further research.
Kawthar Alhussieni, R. Othman, Tamilanban Thamaraikani et al.· Journal of Computer-Aided Mo...· 1 citation
The findings suggest no significant association between the HTR2A rs6313 and ASD susceptibility in the Jordanian population, and emphasize the need for larger, multi-marker studies to account for regional genetic diversity.
Wiam Khalil, Elaf Adel Al-Dalabeeh, M. Zihlif· Drug Metabolism and Personal...· 0 citations
There is a lack of association between the CYP4F2 rs2108622 genotype and valsartan and amlodipine responses among a sample of Jordanians with essential hypertension, and the absence of statistical significance supports the need for larger pharmacogenetic studies.
Y. Jarrar, Enas Yousef Alkasasbeh, Dalia Abdelrazaq et al.· Prostaglandins & other lipid...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.